BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
Rhea-AI Summary
BD (NYSE: BDX) has appointed Bilal Muhsin as Executive Vice President and future President of its Connected Care segment, effective July 2, 2025. Muhsin, who will report to CEO Tom Polen, joins from Masimo where he served as COO during his 25-year tenure.
In this newly created role, Muhsin will lead BD's Connected Care strategy, focusing on advanced analytics and AI solutions alongside smart devices to enhance patient care efficiency. The appointment aligns with BD's transformation into a pure-play MedTech leader, emphasizing connected medication management, advanced workflow robotics, and smart monitoring solutions.
Muhsin brings significant expertise in medical engineering and software development, holding over 50 patents in Medical Systems Communication, Analytics, and Patient Monitoring Systems.
Positive
- Strategic appointment of experienced executive with 25 years in healthcare technology
- Focus on AI and advanced analytics positions BD for digital healthcare transformation
- Appointment supports BD's strategic transition to pure-play MedTech leadership
- New leader brings strong innovation credentials with over 50 patents
Negative
- None.
News Market Reaction
On the day this news was published, BDX gained 0.97%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Under Bilal's leadership, BD Connected Care will aim to leverage advanced analytics and AI solutions alongside BD's industry-leading smart devices to improve the efficiency and effectiveness of patient care while driving compelling growth opportunities in new areas of health care, such as connected medication management, advanced workflow robotics and smart monitoring solutions. In this newly created role, Muhsin will be responsible for advancing BD's future Connected Care strategy, including shaping organizational capabilities, driving and executing the commercial strategy, accelerating industry-leading innovation initiatives, and ensuring operational and quality excellence.
"With his extensive and deep knowledge of connected care technologies, software and informatics strategies, combined with his intense focus on the customer, Bilal will have a profound impact at BD as we advance our connected care strategy with cutting-edge, AI-driven technology that transforms patient care by improving safety, efficiency and outcomes," said Polen. "This is another step forward in advancing our New BD strategy as a differentiated, pure-play MedTech leader, and Bilal will play a critical role in helping BD accelerate our growth and impact on healthcare by capitalizing on the significant digital, robotic and AI technology innovation that we are so well-positioned to capitalize on."
Muhsin joins BD from Masimo, a health technology and consumer electronics manufacturer, where he spent 25 years, most recently as chief operating officer. Prior to that, Bilal held several other leadership roles at Masimo, including executive vice president of engineering, marketing and regulatory. Muhsin has decades of experience with a proven track record in medical engineering and software development, and holds more than 50 patents in Medical Systems Communication, Analytics and Patient Monitoring Systems.
Muhsin holds a Bachelor of Science degree in Computer Science from San Diego State University.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Fallon McLoughlin | Adam Reiffe |
BD Corporate Communications | BD Investor Relations |
201.258.0361 | 201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-appoints-bilal-muhsin-as-executive-vice-president-and-president-of-future-connected-care-segment-302499228.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
Who is the new Connected Care segment president at BD (BDX)?
What is Bilal Muhsin's background before joining BD (BDX)?
What will be Bilal Muhsin's responsibilities at BD (BDX)?
How does this appointment align with BD's (BDX) strategy?
Who will Bilal Muhsin report to at BD (BDX)?
